Multivariate RRs and 95% CIs of prostate cancer, according to categories of dairy food consumption in the PLCO study
Dairy product intake (servings/day)* | Ptrend† | |||||||
---|---|---|---|---|---|---|---|---|
Total dairy | ≤0.98 | 0.99-1.67 | 1.68-2.74 | ≥2.75 | ||||
Total cases | 434 | 451 | 521 | 504 | ||||
RR (95% CI)‡ | 1.00 (referent) | 0.99 (0.86-1.13) | 1.13 (0.99-1.30) | 1.12 (0.97-1.30) | 0.06 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 0.98 (0.85-1.13) | 1.11 (0.95-1.30) | 1.06 (0.88-1.30) | 0.44 | |||
Nonaggressive cases§ | 236 | 238 | 305 | 310 | ||||
RR (95% CI)‡ | 1.00 (referent) | 0.94 (0.78-1.13) | 1.17 (0.98-1.40) | 1.20 (0.99-1.46) | 0.01 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 0.93 (0.77-1.12) | 1.14 (0.92-1.40) | 1.06 (0.82-1.38) | 0.48 | |||
Aggressive cases | 190 | 207 | 207 | 187 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.07 (0.87-1.31) | 1.08 (0.88-1.33) | 1.02 (0.81-1.28) | 0.99 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.06 (0.86-1.31) | 1.08 (0.85-1.38) | 1.07 (0.79-1.45) | 0.73 | |||
Low-fat dairy | ≤0.08 | 0.09-0.41 | 0.42-0.99 | ≥1.00 | ||||
Total cases | 424 | 483 | 478 | 525 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.14 (1.00-1.30) | 1.12 (0.98-1.28) | 1.23 (1.07-1.41) | 0.02 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.14 (1.00-1.30) | 1.11 (0.96-1.28) | 1.19 (1.00-1.41) | 0.13 | |||
Nonaggressive cases§ | 239 | 263 | 259 | 328 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.08 (0.90-1.29) | 1.04 (0.87-1.25) | 1.30 (1.09-1.55) | 0.003 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.08 (0.90-1.29) | 1.03 (0.85-1.24) | 1.20 (0.96-1.50) | 0.12 | |||
Aggressive cases | 177 | 213 | 211 | 190 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.23 (1.01-1.51) | 1.22 (0.99-1.49) | 1.12 (0.90-1.39) | 0.93 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.23 (1.00-1.51) | 1.22 (0.98-1.51) | 1.17 (0.90-1.53) | 0.66 | |||
High-fat dairy | ≤0.10 | 0.11-0.25 | 0.26-0.52 | ≥0.53 | ||||
Total cases | 466 | 496 | 478 | 470 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.09 (0.96-1.24) | 1.04 (0.91-1.20) | 1.07 (0.92-1.23) | 0.65 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.09 (0.95-1.24) | 1.04 (0.91-1.19) | 1.05 (0.91-1.21) | 0.82 | |||
Nonaggressive cases§ | 262 | 282 | 274 | 271 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.06 (0.89-1.26) | 1.01 (0.84-1.20) | 1.03 (0.85-1.24) | 0.99 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.06 (0.89-1.26) | 1.00 (0.84-1.20) | 1.00 (0.83-1.21) | 0.80 | |||
Aggressive cases | 198 | 205 | 195 | 193 | ||||
RR (95% CI)‡ | 1.00 (referent) | 1.11 (0.91-1.36) | 1.08 (0.88-1.34) | 1.13 (0.91-1.42) | 0.42 | |||
RR (95% CI)‡ + diet calcium | 1.00 (referent) | 1.11 (0.91-1.36) | 1.08 (0.88-1.33) | 1.13 (0.91-1.42) | 0.43 |
↵* Dairy food consumption categorized as quartiles.
↵† P trend was based on the medians of the categories.
↵‡ RRs adjusted for age, race, study center, family history of prostate cancer, body mass index, smoking status, physical activity, history of diabetes, red meat intake, total energy intake, education, and number of screening examinations during the follow-up period.
↵§ Nonaggressive cases were defined as Gleason score <7 and stage I/II. Thirty cases were deleted due to missing data on Gleason sum or tumor stage. Aggresive cases were defined as Gleason score ≥7 or stage ≥ III